BioNTech SE has appointed Ramon Zapata-Gomez as its new CFO, effective July 1, 2025. With extensive experience from Novartis, Zapata-Gomez is poised to lead BioNTech's financial st...
BioNTech SE appoints Ramon Zapata-Gomez as its new CFO effective July 2025, bringing extensive financial leadership experience from Novartis. Helmut Jeggle commends his expertise a...
BioNTech SE appoints Ramon Zapata-Gomez as new CFO, effective July 1, 2025, succeeding Jens Holstein. With extensive experience from Novartis, Zapata-Gomez is set to bring global f...
BioNTech SE has named Ramon Zapata-Gomez as its new CFO, effective July 1, 2025, bringing global finance expertise from Novartis. Chairman Helmut Jeggle praises his leadership and ...
BioNTech SE reported a 2.5% decrease in Q1 2025 revenue to €182.8 billion, missing estimates, with a net loss of €415.8 million. The company maintains its fiscal 2025 revenue guida...
BioNTech SE reports a 2.5% decrease in Q1 revenue to €182.8M, missing estimates, with a net loss of €415.8M. The company maintains its revenue guidance for fiscal 2025 and announce...
BioNTech SE appoints Ramon Zapata-Gomez as new CFO effective July 1, 2025, bringing extensive experience from Novartis. Chairman Helmut Jeggle praises his finance expertise and lea...
BioNTech SE announced a 24.4% year-over-year decrease in Q4 2024 revenue to €1.2 billion, exceeding analysts' expectations. The company also reported a net profit of €259.5 million...
BioNTech SE announced a 24.4% year-over-year decrease in Q4 revenue to €1.2 billion, surpassing analysts' expectations. Despite a net profit drop to €259.5 million from €457.9 mill...
BioNTech SE announced a Q4 revenue of €1.2 billion for fiscal 2024, surpassing expectations despite a year-over-year decrease. The company also reported a net profit of €259.5 mill...
BioNTech SE announced a Q4 revenue of €1.2 billion for fiscal 2024, a 24.4% year-over-year decrease but surpassing analysts' expectations. The company reported a net profit of €259...
BioNTech SE announced a Q4 2024 revenue of €1.2 billion, exceeding expectations despite a 24.4% year-over-year decrease. The company reported a net profit of €259.5 million, with d...
BioNTech SE announced a 24.4% year-over-year decrease in Q4 revenue to €1.2 billion, with net profit and EPS also declining. The full fiscal year saw total revenues drop to €2.7 bi...
